ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma

Objectives: ARNTL2, as a circadian transcription factor, has been recently proposed to play an important role in a variety of tumors. however, the role of ARNTL2 in lung carcinogenesis and progression remains unclear. The purpose of this study was to investigate the effect of ARNTL2 on the clinical...

Full description

Bibliographic Details
Main Authors: Huan Zhang, Guangyao Shan, Xing Jin, Xiangyang Yu, GuoShu Bi, Mingxiang Feng, Hao Wang, Miao Lin, Cheng Zhan, Qun Wang, Ming Li
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Translational Oncology
Subjects:
ARNTL2
Lung adenocarcinoma
EMT
Ferroptosis
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322002212

Similar Items

Similar Items